These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 30273889

  • 1. Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome.
    Wauters L, Vanuytsel T.
    Curr Opin Pharmacol; 2018 Dec; 43():118-123. PubMed ID: 30273889
    [Abstract] [Full Text] [Related]

  • 2. Gut hormones in the treatment of short-bowel syndrome and intestinal failure.
    Jeppesen PB.
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):14-20. PubMed ID: 25485516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New approaches to the treatments of short bowel syndrome-associated intestinal failure.
    Jeppesen PB.
    Curr Opin Gastroenterol; 2014 Mar; 30(2):182-8. PubMed ID: 24406477
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB.
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ.
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [Abstract] [Full Text] [Related]

  • 12. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of short bowel syndrome: Breaking the therapeutic ceiling?
    Wauters L, Joly F.
    Nutr Clin Pract; 2023 May; 38 Suppl 1():S76-S87. PubMed ID: 37115030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Is there life after teduglutide?].
    Martínez Martínez AL, Calles Romero LA, Etxeberría Martín E, Monasterio Jiménez O, Zabalegui Eguinoa A, Paja Fano M, Monzón Mendiolea A, Cadenas González A, Cabriada Nuno JL, Iglesias Hernández NC.
    Nutr Hosp; 2020 Jul 13; 34(3):631-635. PubMed ID: 32406744
    [Abstract] [Full Text] [Related]

  • 17. The place of octreotide in the medical management of the dumping syndrome.
    Scarpignato C.
    Digestion; 1996 Jul 13; 57 Suppl 1():114-8. PubMed ID: 8813487
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
    Madsen KB, Askov-Hansen C, Naimi RM, Brandt CF, Hartmann B, Holst JJ, Mortensen PB, Jeppesen PB.
    Regul Pept; 2013 Jun 10; 184():30-9. PubMed ID: 23511332
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.